Omega-3 Prescription Drugs Market Players:
- AstraZeneca plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amarin Corporation plc
- Camber Pharmaceuticals, Inc.
- Dr. Reddy’s Laboratories Ltd.
- GSK plc
- Grupo Ferrer Internacional, S.A.
- Hikma Pharmaceuticals PLC
- Natco Pharma Limited
- Pfizer Inc.
- Viatris Inc.
- Zydus Lifesciences Limited
The omega-3 prescription drugs market remains fiercely competitive among key players such as Amarin Corporation, Hikma Pharmaceuticals, Nordic Naturals, and DSM. These firms are emphasizing product innovation, strategic collaborations, and further expansion of their global reach. Vascepa by Amarin is among the popular products in the market, especially in cardiovascular health, whereas Hikma and Nordic Naturals continue expanding their product offerings within related markets. For example, In March 2023, Hikma Pharmaceuticals launched Icosapent Ethyl Capsules in the U.S., expanding its omega-3 prescription drugs portfolio. This is indicative of growing consciousness toward the prevention of cardiovascular diseases and exemplifies increasing competition amongst key players in the industry.
Here are some leading players in the omega-3 prescription drugs market:
